Autoimmune Skin Diseases I PDF
Document Details
Uploaded by CushyWoodland
College of Veterinary Medicine
Paulo Gomes
Tags
Summary
This document is a lecture or course material on autoimmune skin diseases. It covers different types of pemphigus (foliaceous, erythematous, vulgaris) and discoid lupus erythematosus. The document explains the clinical signs, diagnosis, and treatment options for these conditions, focusing on veterinary medicine.
Full Transcript
AUTOIMMUNE SKIN DISEASES VCS 80610 – Small Animal Medicine I PAULO GOMES, DVM, DACVD COLLEGE OF VETERINARY MEDICINE CLINICAL ASSISTANT PROFESSOR OF VETERINARY DERMATOLOGY DEPARTMENT OF VETERINARY CLINICAL SCIENCES Outline Ø Pemphigus Complex ü Pemphigus foliaceous ü Pemphigus erythematosus ü P...
AUTOIMMUNE SKIN DISEASES VCS 80610 – Small Animal Medicine I PAULO GOMES, DVM, DACVD COLLEGE OF VETERINARY MEDICINE CLINICAL ASSISTANT PROFESSOR OF VETERINARY DERMATOLOGY DEPARTMENT OF VETERINARY CLINICAL SCIENCES Outline Ø Pemphigus Complex ü Pemphigus foliaceous ü Pemphigus erythematosus ü Pemphigus vulgaris Ø Discoid Lupus Erythematosus Pemphigus Complex Ø Autoimmunity is a condition characterized by a specific humoral or cell-mediated immune response against the component of adhesion molecules on keratinocytes Ø Three most common forms of Pemphigus ü Pemphigus foliaceous ü Pemphigus erythematous ü Pemphigus vulgaris Pemphigus Complex Ø Pathomechanism ü Antibodies (IgG) directed against adhesion molecules within the desmosomes ü Desmosomes • Epidermal intercellular structure that holds the cells together ü Targeted adhesion molecules • Desmoglein or desmocollin Pemphigus Complex Ø Pathomechanism ü The final result of IgG binding to desmoglein/desmocollin • Acantholysis (cells detach from each other) ü Acantholytic cells are detached immature keratinocytes that are the hallmark of pemphigus Pemphigus Complex Ø Forms of pemphigus ü Superficial – lesions are formed underneath the stratum corneum or inside the stratum granulosum • Pemphigus foliaceus • Pemphigus erythematous ü Deep – lesions are formed just above the basal cell layer • Pemphigus vulgaris Pemphigus Foliaceus Ø The most common autoimmune skin disease of dogs and cats ü Animals of any age, breed, or sex can be affected ü Akitas and chow chows seem to be over-represented Ø Usually idiopathic, but in some cases can be induced by drugs or chronic inflammation ü Acute onset ü Systemic signs are uncommon: lymphadenomegaly, limb edema, fever, anorexia, and depression Pemphigus Foliaceus Ø Primary lesions ü Pustules • Difficult to find because they rupture very easily • Obscured by the haircoat Ø Secondary lesions ü Crusts, scales, collarettes, alopecia, erosions, and erythema Ø Footpad hyperkeratosis Ø Pruritus and pain are variable Pemphigus Foliaceus Ø Distribution of lesions ü ü ü ü ü Nasal planum Ear pinnae Footpads Paronychia: often seen in cats Crusts on the nipple. Usually present in cats Ø Begins on the bridge of the nose, around the eyes, and pinnae before it becomes generalized Ø Oral lesions and mucocutaneous involvement are very rare and if present are minimal Pemphigus foliaceus: frequently starts on the face especially the dorsal aspect of the nose and the nasal planum. Pemphigus foliaceous: pinnae involvement. Pemphigus foliaceus: footpad hyperkeratosis. Pemphigus foliaceus: generalized – crusts, scales, alopecia, erosions, and erythema. Pemphigus foliaceus: crusts, scales, alopecia, erosions, and erythema on the bridge of the nose, head, and pinnae. Pemphigus foliaceus: Cat – hyperkeratosis of the footpads, and paronychia (inflammation of the nail fold). Pemphigus Foliaceus Ø Differential diagnosis ü Bacterial folliculitis ü Dermatophytosis ü Other immune mediated diseases • Pemphigus complex, SLE, DLE, bullous pemphigoid, dermatomyositis ü Drug eruption, zinc-responsive dermatitis, cutaneous lymphoma, superficial necrolytic dermatitis, demodicosis, and mosquito bite hypersensitivity in cats Pemphigus Foliaceus Ø Diagnosis ü Middle age adult dogs ü Acute onset and gradual progression of skin lesions ü Lesions on the nasal planum, ear pinnae, and footpads are characteristic of autoimmune skin disease ü Nasal depigmentation frequently accompanies facial lesion ü Cytology of pustules ü Dermatohistopathology ü Immunofluorescence or immunohistochemistry: usually not performed on a clinical setting ü Bacterial culture: if secondary infections are present Pemphigus Foliaceus Ø Diagnosis ü Cytology of a pustule • If pustule not present - collect sample from underneath a crust • Nondegenerated neutrophils, multiple acantholytic keratinocytes, +/- eosinophils, no bacteria Pemphigus foliaceus: Cytology – several acantholytic cells (arrow) and nondegenerated neutrophils Pemphigus Foliaceus Ø Diagnosis ü Histopathology • The most important test for a definitive diagnosis • Sub corneal or intraepidermal pustule with neutrophils, variable numbers of eosinophils and acantholytic cells Pemphigus foliaceus: histopathology - subcorneal pustule several acantholytic cells and nondegenerated neutrophils Pemphigus Foliaceus Ø Diagnosis ü Direct Immunofluorescence or immunoperoxidase • Intercellular staining of Immunoglobulins • Sample – skin biopsy • Immunofluorescence - Michel’s solution • Immunoperoxidase - Formalin • False negatives/false positives Pemphigus foliaceus: Immunofluorescence – intercellular staining of immunoglobulins Pemphigus Foliaceus Ø Diagnosis ü Indirect Immunofluorescence • Sample - serum • Usually low titer or negative results ü CBC, chemistry profile, UA • Usually normal • Inflammatory changes may be seen ü Antinuclear antibody (ANA): negative Pemphigus Erythematosus (PE) Ø Uncommon in dogs and rare in cats Ø Increased incidence: German shepherds, collies, and Shetland sheepdogs Ø Considered a benign form of pemphigus foliaceous or a crossover between pemphigus and lupus erythematosus Ø It does have some similarities with lupus erythematous ü ANA may be positive but not pathognomonic of PE ü Immunofluorescence similar to both, pemphigus (intercellular staining) and lupus (staining along basement membrane) ü Lesions are aggravated by UV light Pemphigus Erythematosus Ø Distribution of lesions ü Face (nasal planum and dorsal muzzle) and ear pinnae only ü Oral cavity is not involved Ø Histopathology ü Lesions characteristic of pemphigus foliaceus ü Lesions characteristic of lupus erythematosus • Basal keratinocyte vacuolization and presence of apoptotic cells in the basal layer ü Histopathology is the most important test for a definitive diagnosis Pemphigus erythematosus Pemphigus Vulgaris Ø Uncommon to rare Ø It is the ulcerative and most severe form of pemphigus Ø Autoantibodies against antigen in or near the epidermaldermal junction Ø Primary lesions ü Vesicles and bulla Ø Secondary lesions ü Erosions, ulcers, and occasionally crusts ü Most commonly seen Pemphigus Vulgaris Ø Distribution of lesions ü Mucocutaneous regions • Lips, nares, eyelids, mouth, anus, genitalia ü Nail beds, inguinal, and axillary areas ü Erosions, ulcerations, and rarely vesicle and bullae • Oral cavity affected in about 80% of the cases • Marked salivation and halitosis Ø Animals can become sick and present with anorexia, fever and depression Pemphigus Vulgaris Ø Differential diagnosis ü Bullous pemphigoid, systemic lupus erythematosus, erythema multiforme, toxic epidermal necrolysis, drug reaction, vasculitis, cutaneous epitheliotropic lymphoma, bacterial and fungal infections Pemphigus vulgaris: erosions and ulcerations in mucocutaneous areas Pemphigus vulgaris: erosion and erythema affecting oral mucosa Pemphigus vulgaris: erosion and ulcer on vaginal mucosa Pemphigus vulgaris: cytology - acantholytic cells and neutrophils Pemphigus Vulgaris Ø Cytology ü Acanthocytes and neutrophils Ø Histopathology ü Suprabasilar acantholysis and cleft forming a vesicle or bulla which will contain acanthocytes and neutrophils. Basal cells will have a “tombstone” appearance. Hair follicles may be involved Pemphigus Complex Ø Treatment ü Typically combination of therapies have been used to achieve remission and minimize adverse effects of any one therapy ü Oral glucocorticoids • Immunosuppressive doses • Once remission has been achieved - gradually decrease to low dose alternate day medication • Prednisone, prednisolone, dexamethasone, triamcinolone Pemphigus Complex Ø Treatment ü Recheck in 14 days ü About 50% respond to oral glucocorticoids alone ü Cytotoxic Drugs • Consider if no significant response after 10 to 14 days of glucocorticoids and/or severe side effects • Can be used initially with glucocorticoids • Dogs: Azathioprine, chlorambucil, dapsone • Cats: Chlorambucil Pemphigus Complex Ø Aggressive treatments with few studies documenting efficacy and safety ü Glucocorticoid pulse therapy • Very high doses for 3 days followed by reduced daily dose • Pulses are repeated as needed ü Mycophenolate mofetil ü Leflunomide Ø It is unclear if Cyclosporine is an efficacious treatment for canine pemphigus foliaceous Pemphigus Complex Ø Client education ü It is a controllable but not curable disease ü Multiple recheck visits will be needed until the ideal treatment protocol is determined ü Response to therapy is variable and unpredictable ü There are potentially severe side effects associated with the immunosuppressive treatment ü Complications: drug adverse effects, secondary bacterial infections, fungal infections, and demodicosis Discoid Lupus Erythematosus (DLE) Ø The second most common autoimmune skin disease after pemphigus foliaceous in dogs Ø Uncommon in cats Ø Only the skin is affected Ø No systemic signs Discoid Lupus Erythematosus Ø Hypothesis for the pathogenesis of skin lesions in genetically susceptible individuals ü Ultraviolet light (UVB/UVA) penetrates to the level of epidermal basal cells induces, on the keratinocyte surface, the enhanced expression of intercellular adhesion molecule-1 (ICAM-1) and of autoantigens previously found only in the nucleus or cytoplasm ü Specific autoantibodies to these antigens, that are present in plasma and in tissues attach to keratinocytes and induce antibodydependent cytotoxicity of keratinocytes ü Injured keratinocytes release interleukin-2 (IL-2) and other lymphocyte chemoattractants, resulting in a lymphohistiocytic infiltrate. Inappropriate activation of keratinocyte apoptosis Discoid Lupus Erythematosus Ø Clinical Signs ü Lesions • Usually start as depigmentation and erythema of the nasal planum • Progress to erosions, ulcers, scaling and crusts • Lesions may heal with atrophic scars • Loss of normal cobblestone architecture of the nose • Lesions are exacerbated by sunlight ü Distribution • Most often limited to the nasal planum and dorsal muzzle Discoid Lupus Erythematosus: depigmentation, erythema, erosions, scaling, crusts, and loss of normal cobblestone appearance of the nasal planum Discoid Lupus Erythematosus: erosion on oral mucosa, and crust on ear flap (areas uncommonly affected) Discoid Lupus Erythematosus Ø Differentials diagnosis ü Nasal pyoderma, nasal solar dermatitis, pemphigus foliaceus, pemphigus erythematous, uveodermatologic syndrome, bullous pemphigoid, dermatomyositis, and mosquito bite hypersensitivity in cats Ø Cytology ü No significant findings Discoid Lupus Erythematosus Ø Histopathology ü Skin biopsy ü Interface dermatitis reaction ü Hydropic-vacuolar changes at the basement membrane zone and basal cell layer or lichenoid band-like infiltrate at the dermoepidermal junction ü Individual necrosis of keratinocytes in the lower epidermis; dermal infiltrates consisting of lymphocytes and plasma cells and pigmentary incontinence are additional findings Discoid Lupus Erythematosus Ø Direct immunofluorescence or immunoperoxidase ü Non-diagnostic ü Deposition of immunoglobulin or complement at the basement membrane ü Fluorescence at the dermoepidermal junction ü Do not rule out discoid lupus if the results are negative ü Michel’s solution - immunofluorescence ü Formalin – immunoperoxidase Ø Antinuclear antibody (ANA) ü Negative or very low titer Discoid Lupus Erythematosus: direct immunofluorescence – fluorescence at the dermoepidermal junction Discoid Lupus Erythematosus Ø Treatment ü Mild cases • Systemic vitamin E o 400-800 IU q12h PO • Tetracycline and Niacinamide o < 10 Kg: 250 mg of each TID o > 10 Kg: 500 mg of each TID • Topical steroids o Be aware of skin atrophy Discoid Lupus Erythematosus Ø Treatment ü All cases • Tacrolimus ointment o Protopic® 0.1% • Sunscreens with SPF 15 or higher ü Severe cases • Systemic steroids in conjunction with one or more of the medications recommended for mild cases • Once in remission, steroids should be given q48h Discoid Lupus Erythematosus Ø Treatment ü Severe cases • Many cases can be tapered off the systemic steroids and maintained on just tetracycline + niacinamide, topical steroids or tracrolimus, vitamin E and sunscreens • Oral cyclosporine (microemulsion) o Dose 5mg/kg/day o If given in conjunction with ketoconazole, reduce the dosage to half Discoid Lupus Erythematosus Ø Client education ü Prognosis is good ü Lifelong treatment is usually necessary ü Only the skin is affected ü Sunlight can aggravate the disease ü Squamous cell carcinoma is a possible complication ü Various treatments may be needed before the ideal maintenance regimen is found